NanoViricides inks deal with Bioanalytical Systems for safety, toxicology studies needed for FDA sub – Proactiveinvestors (UK)

NanoViricides inks deal with Bioanalytical Systems for safety, toxicology studies needed for FDA sub – Proactiveinvestors (UK).

NanoViricides (OTCBB: NNVC) says it has agreed with Bioanalytical Systems (NASDAQ:BASI) to conduct drug development studies required for submitting investigational new drug applications (IND) for its NanoViricides to the FDA.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: